NO20012965D0 - Sulfonyloksazolaminer som terapeutisk aktive forbindelser - Google Patents
Sulfonyloksazolaminer som terapeutisk aktive forbindelserInfo
- Publication number
- NO20012965D0 NO20012965D0 NO20012965A NO20012965A NO20012965D0 NO 20012965 D0 NO20012965 D0 NO 20012965D0 NO 20012965 A NO20012965 A NO 20012965A NO 20012965 A NO20012965 A NO 20012965A NO 20012965 D0 NO20012965 D0 NO 20012965D0
- Authority
- NO
- Norway
- Prior art keywords
- sulfonyloxazolamines
- active compounds
- therapeutically active
- therapeutically
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D263/34—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D263/48—Nitrogen atoms not forming part of a nitro radical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19858593A DE19858593A1 (de) | 1998-12-18 | 1998-12-18 | Sulfonyloxazolamine als therapeutische Wirkstoffe |
| PCT/EP1999/009335 WO2000037452A1 (de) | 1998-12-18 | 1999-12-01 | Sulfonyloxazolamine als therapeutische wirkstoffe |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20012965D0 true NO20012965D0 (no) | 2001-06-15 |
| NO20012965L NO20012965L (no) | 2001-06-15 |
Family
ID=7891645
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20012965A NO20012965L (no) | 1998-12-18 | 2001-06-15 | Sulfonyloksazolaminer som terapeutisk aktive forbindelser |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US6441013B1 (sk) |
| EP (1) | EP1140875A1 (sk) |
| JP (1) | JP2002533332A (sk) |
| CN (1) | CN1146549C (sk) |
| AR (1) | AR021896A1 (sk) |
| AU (1) | AU763070B2 (sk) |
| BR (1) | BR9916310A (sk) |
| CA (1) | CA2356134A1 (sk) |
| CZ (1) | CZ20012144A3 (sk) |
| DE (1) | DE19858593A1 (sk) |
| HK (1) | HK1043125A1 (sk) |
| HU (1) | HUP0104834A3 (sk) |
| ID (1) | ID29966A (sk) |
| NO (1) | NO20012965L (sk) |
| PL (1) | PL349393A1 (sk) |
| RU (1) | RU2232757C2 (sk) |
| SK (1) | SK8132001A3 (sk) |
| WO (1) | WO2000037452A1 (sk) |
| ZA (1) | ZA200105881B (sk) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19956791A1 (de) * | 1999-11-25 | 2001-05-31 | Merck Patent Gmbh | Neue Sulfonyloxazolamine |
| DE10129940A1 (de) * | 2001-06-13 | 2002-12-19 | Merck Patent Gmbh | Sulfonyloxazolamine als therapeutische Wirkstoffe |
| US6875771B2 (en) | 2002-07-26 | 2005-04-05 | Bristol-Myers Squibb Company | Pyridopyrimidine derivatives as 5-HT6 antagonists |
| FR2854632B1 (fr) * | 2003-05-07 | 2005-06-17 | Centre Nat Rech Scient | Synthese de composes heterocycliques substitues |
| RU2396255C2 (ru) * | 2004-12-21 | 2010-08-10 | Ф. Хоффманн-Ля Рош Аг | Производные тетралина и индана и их применения |
| CN101233119A (zh) * | 2005-07-29 | 2008-07-30 | 4Sc股份有限公司 | 新型杂环NF-κB抑制剂 |
| US8394788B2 (en) * | 2006-11-16 | 2013-03-12 | The Regents Of The University Of California | Phenylsulfoxyoxazole compound inhibitors of urea transporters |
| AU2008209860A1 (en) * | 2007-02-02 | 2008-08-07 | F. Hoffmann-La Roche Ag | Novel 2-aminooxazolines as TAAR1 ligands for CNS disorders |
| KR101222412B1 (ko) * | 2007-02-15 | 2013-01-15 | 에프. 호프만-라 로슈 아게 | Ｔａａｒ1 리간드로서의 2-아미노옥사졸린 |
| RU2443697C1 (ru) | 2010-12-21 | 2012-02-27 | Александр Васильевич Иващенко | Замещенные метил-амины, антагонисты серотониновых 5-ht6 рецепторов, способы получения и применения |
| CN109789129B (zh) * | 2016-07-12 | 2022-04-29 | 延世大学校产学协力团 | 自噬改良材料及其用途 |
| KR102533605B1 (ko) * | 2018-01-10 | 2023-05-17 | 주식회사 라이조테크 | 신규한 페닐설포닐 옥사졸 유도체 및 이의 용도 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CZ263098A3 (cs) * | 1996-02-20 | 1999-05-12 | Bristol-Myers Squibb Company | Způsoby přípravy bifenylisoxazolsulfonamidů |
-
1998
- 1998-12-18 DE DE19858593A patent/DE19858593A1/de not_active Withdrawn
-
1999
- 1999-12-01 EP EP99962190A patent/EP1140875A1/de not_active Withdrawn
- 1999-12-01 JP JP2000589524A patent/JP2002533332A/ja active Pending
- 1999-12-01 CA CA002356134A patent/CA2356134A1/en not_active Abandoned
- 1999-12-01 US US09/868,097 patent/US6441013B1/en not_active Expired - Fee Related
- 1999-12-01 WO PCT/EP1999/009335 patent/WO2000037452A1/de not_active Application Discontinuation
- 1999-12-01 BR BR9916310-1A patent/BR9916310A/pt not_active IP Right Cessation
- 1999-12-01 RU RU2001119273/04A patent/RU2232757C2/ru not_active IP Right Cessation
- 1999-12-01 ID IDW00200101555A patent/ID29966A/id unknown
- 1999-12-01 CZ CZ20012144A patent/CZ20012144A3/cs unknown
- 1999-12-01 SK SK813-2001A patent/SK8132001A3/sk unknown
- 1999-12-01 AU AU18612/00A patent/AU763070B2/en not_active Ceased
- 1999-12-01 CN CNB998147281A patent/CN1146549C/zh not_active Expired - Fee Related
- 1999-12-01 HU HU0104834A patent/HUP0104834A3/hu unknown
- 1999-12-01 PL PL99349393A patent/PL349393A1/xx unknown
- 1999-12-17 AR ARP990106528A patent/AR021896A1/es not_active Application Discontinuation
-
2001
- 2001-06-15 NO NO20012965A patent/NO20012965L/no not_active Application Discontinuation
- 2001-07-17 ZA ZA200105881A patent/ZA200105881B/en unknown
-
2002
- 2002-07-02 HK HK02104944.7A patent/HK1043125A1/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AR021896A1 (es) | 2002-08-07 |
| AU763070B2 (en) | 2003-07-10 |
| AU1861200A (en) | 2000-07-12 |
| HUP0104834A3 (en) | 2005-06-28 |
| CA2356134A1 (en) | 2000-06-29 |
| US6441013B1 (en) | 2002-08-27 |
| SK8132001A3 (en) | 2002-02-05 |
| NO20012965L (no) | 2001-06-15 |
| RU2232757C2 (ru) | 2004-07-20 |
| BR9916310A (pt) | 2001-11-06 |
| WO2000037452A1 (de) | 2000-06-29 |
| CZ20012144A3 (cs) | 2002-01-16 |
| CN1331684A (zh) | 2002-01-16 |
| ID29966A (id) | 2001-10-25 |
| HUP0104834A2 (hu) | 2002-07-29 |
| HK1043125A1 (zh) | 2002-09-06 |
| PL349393A1 (en) | 2002-07-15 |
| ZA200105881B (en) | 2002-10-17 |
| EP1140875A1 (de) | 2001-10-10 |
| JP2002533332A (ja) | 2002-10-08 |
| DE19858593A1 (de) | 2000-06-21 |
| CN1146549C (zh) | 2004-04-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20014412D0 (no) | Forbindelser nyttige som anti-inflammatoriske midler | |
| PT1220856E (pt) | Compostos farmaceuticamente activos | |
| EE200000438A (et) | Farmatseutiliselt aktiivne morfolinool | |
| NO20011738D0 (no) | Heterocyclylaminometyloksazolidinoner som antibakterielle midler | |
| EE200100502A (et) | Ühendid | |
| DE69926752D1 (de) | Therapeutisch wirksame biaryl-derivate | |
| IS6239A (is) | Ný efnasambönd | |
| DK0975623T3 (da) | Indazolamidforbindelser som sertoninerge midler | |
| IS6139A (is) | Ný efnasambönd | |
| NO20012965D0 (no) | Sulfonyloksazolaminer som terapeutisk aktive forbindelser | |
| DK1086097T3 (da) | Sulfonylbenzenforbindelser som anti-inflammatoriske/analgetiske midler | |
| DK1144431T3 (da) | 16-Hydroxyestratriener som selektivt aktive estrogener | |
| NO20013769L (no) | Kalsilytiske forbindelser | |
| NO20020466L (no) | Kalsilytiske forbindelser | |
| IS6141A (is) | Ný efnasambönd | |
| DE59911707D1 (de) | Fungizide wirkstoffkombinationen | |
| DE59902159D1 (de) | Aktiver mikromischer | |
| NO20014262D0 (no) | Tiazoloindolinon-forbindelser | |
| DE60034215D1 (de) | Oberflaechenaktive zusammensetzung | |
| DE69930738D1 (de) | Oberflaechenaktive zusammensetzung | |
| DK1380585T3 (da) | Pyrazolopyridinon som mellemprodukt | |
| ID29984A (id) | Senyawa-senyawa bis-stirilbifenil | |
| SE9802539D0 (sv) | New pharmaceutically active compounds | |
| SE9700660D0 (sv) | Pharmaceutically active compounds | |
| SE9704874D0 (sv) | New pharmaceutically active compounds |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |